PEPTONIC medical AB (28L) Stock Statistics & Valuation Metrics

PEPTONIC medical AB has a market cap or net worth of €1.97M. The enterprise value is $2.64M.

PEPTONIC medical AB has 27,580,020,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

PEPTONIC medical AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of PEPTONIC medical AB is ―. PEPTONIC medical AB’s PEG ratio is ―.

In the last 12 months, PEPTONIC medical AB had revenue of ― and earned -73.69M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

PEPTONIC medical AB pays an annual dividend of ―, resulting in a dividend yield of ―

PEPTONIC medical AB upcoming earnings date is Nov 10, 2026, TBA (Not Confirmed).

PEPTONIC medical AB as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, PEPTONIC medical AB has paid ― in taxes.

PEPTONIC medical AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

PEPTONIC medical AB has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for PEPTONIC medical AB is ―, which is 11.43% higher than the current price. The consensus rating is ―